We are live on ! Find out more
VYGR icon

Voyager Therapeutics
VYGR

75 hedge funds and large institutions have $233M invested in Voyager Therapeutics in 2017 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 26 increasing their positions, 12 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

17,071% more call options, than puts

Call options by funds: $3.61M | Put options by funds: $21K

329% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 7

137% more capital invested

Capital invested by funds: $98.1M → $233M (+$135M)

117% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 12

44% more funds holding

Funds holding: 52 → 75 (+23)

1.28% more ownership

Funds ownership: 40.78% → 42.06% (+1.3%)

Holders
75
Holders Change
+23
Holders Change %
+44.23%
% of All Funds
1.87%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
30
Increased
26
Reduced
12
Closed
7
Calls
$3.61M
Puts
$21K
Net Calls
+$3.58M
Net Calls Change
+$3.63M

Top Buyers

Rank Fund Capital Flow
1
Wells Fargo
Wells Fargo
California
+$3.23M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$3.05M
3
EAM
Eventide Asset Management
Massachusetts
+$2.95M
4
Citadel Advisors
Citadel Advisors
Florida
+$2.83M
5
BBA
Baker Bros. Advisors
New York
+$2.67M

Top Sellers

Rank Fund Capital Flow
1
BCPEM
Bain Capital Public Equity Management
Massachusetts
-$10.5M
2
PHS
PFM Health Sciences
California
-$5.14M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$1.35M
4
DCM
DAFNA Capital Management
California
-$988K
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$722K
Name Holding Trade Value Shares
Change 		Change in
Stake
RJFSA
26
Raymond James Financial Services Advisors
Florida
$1.12M +$615K +54,488 New
Charles Schwab
27
Charles Schwab
California
$1.03M +$234K +20,753 +71%
Susquehanna International Group
28
Susquehanna International Group
Pennsylvania
$889K +$487K +43,197 New
TCIM
29
TIAA CREF Investment Management
New York
$768K – – –
PA
30
Perceptive Advisors
New York
$712K – – –
Renaissance Technologies
31
Renaissance Technologies
New York
$686K +$257K +22,800 +217%
Morgan Stanley
32
Morgan Stanley
New York
$640K +$208K +18,470 +146%
Goldman Sachs
33
Goldman Sachs
New York
$580K +$126K +11,124 +65%
SG Americas Securities
34
SG Americas Securities
New York
$577K +$316K +28,029 New
IHM
35
Iguana Healthcare Management
New York
$515K +$282K +25,000 New
BC
36
Birchview Capital
Vermont
$494K +$271K +24,000 New
VF
37
Virtu Financial
New York
$477K +$261K +23,171 New
TA
38
Teachers Advisors
New York
$476K -$29K -2,570 -10%
California State Teachers Retirement System (CalSTRS)
39
California State Teachers Retirement System (CalSTRS)
California
$474K -$31.3K -2,775 -11%
NFA
40
Nationwide Fund Advisors
Ohio
$407K +$100K +8,884 +82%
DCM
41
Driehaus Capital Management
Illinois
$407K +$223K +19,752 New
OC
42
Oppenheimer & Co
New York
$357K +$15.4K +1,365 +9%
RhumbLine Advisers
43
RhumbLine Advisers
Massachusetts
$334K +$1.58K +140 +0.9%
Barclays
44
Barclays
United Kingdom
$301K +$53.3K +4,726 +48%
New York State Common Retirement Fund
45
New York State Common Retirement Fund
New York
$282K +$18.1K +1,600 +13%
Deutsche Bank
46
Deutsche Bank
Germany
$278K -$28.2K -2,495 -16%
JP Morgan Chase
47
JP Morgan Chase
New York
$270K +$156K +13,829 New
Manulife (Manufacturers Life Insurance)
48
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$268K +$138K +12,253 +1,642%
DS
49
DRW Securities
Illinois
$247K +$135K +12,000 New
MLICM
50
Metropolitan Life Insurance Company (MetLife)
New York
$228K +$125K +11,083 New
1
2
3 4

VYGR Hedge Fund Activity: Q3 2017 in Review

75 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Voyager Therapeutics (VYGR) for Q3 2017, worth a combined $233M — up 137% from $98.1M a quarter earlier.

Buyers outnumbered sellers: 30 funds opened new VYGR positions and 7 closed out — a net gain of 23 holders — while 26 added to existing stakes and 12 trimmed.

The largest buyer was Wells Fargo, adding an estimated $3.23M. The largest seller was Bain Capital Public Equity Management, exiting entirely with an estimated $10.5M sold.

  • 75 institutional investors held Voyager Therapeutics (VYGR) as of Q3 2017, up from 52 in Q2 2017.
  • Funds reported $233M of Voyager Therapeutics stock for Q3 2017, up 137% quarter-over-quarter.
  • 30 funds opened new Voyager Therapeutics positions in Q3 2017 and 7 closed out, a net change of +23 holders.
  • The largest Voyager Therapeutics buyer in Q3 2017 was Wells Fargo, an estimated $3.23M added.
  • The largest Voyager Therapeutics seller in Q3 2017 was Bain Capital Public Equity Management, an estimated $10.5M sold.

Based on aggregated 13F filings for Q3 2017.